The m6A reader IGF2BP3 is upregulated in these cells which directly binds with ABCB1 mRNA, promoting its stabilization and overexpression and leading to increased doxorubicin efflux.[63] The m6A eraser FTO is upregulated in metastatic non‐small cell lung cancer (NSCLC), which is associated with overexpression of drug transporter ABCC10. This evidence concerns the gene FTO and non-small cell lung carcinoma.